 |
|
GM2-KLH vaccine
A cancer vaccine consisting of GM2 ganglioside, a melanoma-specific antigen, conjugated with the immunostimulant keyhole limpet hemocyanin. Vaccination with GM2-KLH vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against GM2 ganglioside-expressing melanoma cells, resulting in tumor growth inhibition. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonyms: | | GM2-KLH ganglioside
KLH-conjugated GM2 Ganglioside Vaccine | | | | Abbreviation: | | GM2-KLH | | |
|
|
